Detalhe da pesquisa
1.
Novel promising benzoxazole/benzothiazole-derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis.
Arch Pharm (Weinheim)
; 356(9): e2300097, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37379240
2.
Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations.
J Enzyme Inhib Med Chem
; 37(1): 1556-1567, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35635148
3.
New quinoxalin-2(1H)-one-derived VEGFR-2 inhibitors: Design, synthesis, in vitro anticancer evaluations, in silico ADMET, and docking studies.
Arch Pharm (Weinheim)
; 355(7): e2200048, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35437829
4.
Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation.
Bioorg Chem
; 114: 105105, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34175720
5.
Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors.
Arch Pharm (Weinheim)
; 354(6): e2000456, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33554352
6.
Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
Arch Pharm (Weinheim)
; 354(7): e2000491, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33788290
7.
Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
Arch Pharm (Weinheim)
; 354(2): e2000279, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33073374
8.
Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
Bioorg Chem
; 105: 104399, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33113414
9.
Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents.
Bioorg Chem
; 104: 104218, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32932121
10.
Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme.
Bioorg Chem
; 102: 104059, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32653608
11.
Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors.
Bioorg Chem
; 103: 104233, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32882440
12.
Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors.
Arch Pharm (Weinheim)
; 353(8): e2000068, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32510731
13.
5-(4-Methoxybenzylidene)thiazolidine-2,4-dione-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
Arch Pharm (Weinheim)
; 353(9): e2000079, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32515896
14.
Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors.
Arch Pharm (Weinheim)
; 352(10): e1900113, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31448458
15.
Benzoxazole/benzothiazole-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
Arch Pharm (Weinheim)
; 352(12): e1900178, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31596514
16.
Synthesis and human/bacterial carbonic anhydrase inhibition with a series of sulfonamides incorporating phthalimido moieties.
Bioorg Med Chem
; 25(8): 2524-2529, 2017 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28318894
17.
Design, Synthesis, Molecular Docking, and Anticancer Activity of Phthalazine Derivatives as VEGFR-2 Inhibitors.
Arch Pharm (Weinheim)
; 350(12)2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29131379
18.
Design, synthesis, anticancer evaluation, in silico docking and ADMET analysis of novel indole-based thalidomide analogs as promising immunomodulatory agents.
J Biomol Struct Dyn
; 41(24): 15106-15123, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36889930
19.
Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
Anticancer Agents Med Chem
; 18(8): 1184-1196, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29651967